Could a drug deployed at the earliest hint of Alzheimer’s stop or slow the disease?
Thursday, February 6, 2020 - 11:10
in Health & Medicine
Keck School of Medicine of USC is launching a large clinical study to determine whether a man-made antibody would slow or stop the progression of Alzheimer’s disease by targeting memory-robbing plaques in the earliest stages of the illness. Described as a public-private partnership, the AHEAD 3-45 Study will be conducted with funding from the National Institute on […]